A phase II, randomized, double-blind, two-dose, placebo-controlled multicentre study of 4-hydroxy tamoxifen [afimoxifene] gel for cyclical mastalgia in otherwise healthy pre-menopausal women with regular menstrual cycles

Trial Profile

A phase II, randomized, double-blind, two-dose, placebo-controlled multicentre study of 4-hydroxy tamoxifen [afimoxifene] gel for cyclical mastalgia in otherwise healthy pre-menopausal women with regular menstrual cycles

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2013

At a glance

  • Drugs Afimoxifene (Primary)
  • Indications Breast pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2009 Results were presented at ASCO 2009.
    • 14 Dec 2008 Results were reported at the 31st Annual San Antonio Breast Cancer Symposium.
    • 01 Dec 2007 Results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top